District Court Will Now Hear A Suit On The Merits–Like The Industry Has Lost In Every Other Jurisdiction

P4AD Counters Industry’s Legal Arguments, Recounts The Sordid History Of Big Pharma’s Opposition To Medicare Negotiation And Tells The Court Of The IRA’s Positive Impact On Millions Of Patients

Twenty two years ago, I was diagnosed with Crohn’s disease when I was 17 years old. My name is Rachel Johnston and I am a communications and marketing professional living in Los Angeles, California.

Patients Champion The Law’s Drug Price Reforms, Share How Their Lowered Rx Prices Will Be Game-changing

Today, following the announcement of the new lower prices negotiated through Medicare – which marked a historic shift in drug pricing policy – P4AD patient advocate Judy Aiken, who takes Enbrel, one of the first 10 negotiated drugs, introduced President Biden and Vice President Harris at an event focused on the new lowered prices.

Today, the Biden-Harris administration released the results of its first-ever drug price negotiations through Medicare, marking a historic shift in drug pricing policy and promising significant savings for nearly nine million American patients.

Federal Judge Deals Another Blow To Pharmaceutical Industry Lawsuits, Upholds Medicare’s Drug Price Negotiation Program

Hello, I'm Lisa McRipley – a multiple sclerosis (MS) Activist, District Activist Leader, and former member of the Society's Diversity, Equity, and Inclusion Advisory Committee, Black MS Community Engagement Advisory Committee, and the Michigan Chapter Board of Trustees.